Alembic Pharmaceuticals Limited (BOM:533573)
India · Delayed Price · Currency is INR 820.50
+6.15 (0.76%)
At close: Aug 21, 2026
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 161.53 billion as of August 21, 2026. Its market cap has decreased by -16.34% in one year.
Market Cap
161.53B
Enterprise Value
173.80B
Revenue
77.84B
Ranking
n/a
PE Ratio
23.29
Stock Price
820.50
ChartMarket Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 161.53B, an increase of 1,694.40%. That is a compound annual growth rate of 21.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 161.53B | -2.88% |
| Dec 31, 2025 | 166.32B | -20.64% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 297.76B |
| Granules India | 207.68B |
| Caplin Point Laboratories | 195.43B |
| AstraZeneca Pharma India | 187.71B |
| Jubilant Pharmova | 137.58B |
| CORONA Remedies | 129.75B |
| Viyash Scientific | 118.70B |